Overview

Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether intraocular injection of triamcinolone is effective in the treatment of macular edema in acute branch retinal vein occlusion.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- Eyes suffering from branch retinal vein occlusion with less than 2 months duration.

Exclusion Criteria:

- Monocularity,

- Previous intraocular surgery or laser therapy

- Glaucoma or ocular hypertension

- Significant media opacity

- Existence of traction on the macula

- Visual acuity ≥20/40

- Signs of chronicity (such as cilioretinal and/or retinal shunt vessels)